Height has been linked to an increased risk of certain cancers, including pancreatic, uterine, and breast cancer, due to ...

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

Here are the top 5 most common forms of cancers that can hit your immune system as soon as you cross 30. Check out the cancer ...

The EC has approved GSK's Jemperli (dostarlimab) combined with chemotherapy for primary advanced or recurrent endometrial ...

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

"The lack of a significant link between AmygA and LN metastasis in premenopausal women suggests that menopausal status may ...

GSK (GSK) has received expanded approval from the European Commission for its drug Jemperli, also known as dostarlimab, in the treatment of endometrial cancer. Read more here.

The European Commission approves GSK's Jemperli plus chemotherapy to treat all adult patients with primary, advanced or recurrent endometrial cancer.

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

London: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy ...

This has been linked to lifestyle changes, metabolic diseases, and obesity, with cases increasingly being reported in women ...